| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/29/2006 | WO2006040129A3 Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography |
| 06/29/2006 | WO2005115480A3 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 06/29/2006 | WO2005112886A3 Methods and articles for the delivery of therapeutic agents |
| 06/29/2006 | WO2005110338A3 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 06/29/2006 | WO2005001092A3 Compositions and methods for diagnosing and treating cancers |
| 06/29/2006 | WO2003091413A3 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 06/29/2006 | US20060142557 2'-deoxy-2'alkylnucleotide containing nucleic acid |
| 06/29/2006 | US20060142556 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
| 06/29/2006 | US20060142236 Antisense oligonucleotide modulation of raf gene expression |
| 06/29/2006 | US20060142235 Method of reducing and treating UVB-induced immunosuppression |
| 06/29/2006 | US20060142234 Injectable non-aqueous suspension |
| 06/29/2006 | US20060142233 Gene expression and genetic changes implicated in alcoholism |
| 06/29/2006 | US20060142232 administering an antisense oligomer conjugate comprises an activated disulfide moiety and a bivalent linking group; capable of forming a bio-reversible bond with a plasma protein; stable under plasma blood conditions and unstable under cellular conditions |
| 06/29/2006 | US20060142231 DNA damage repair inhibitors for treatment of cancer |
| 06/29/2006 | US20060142230 Double-stranded ribonucleic acid molecules having ribothymidine |
| 06/29/2006 | US20060142229 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 06/29/2006 | US20060142228 Methods and compositions concerning siRNA's as mediators of RNA interference |
| 06/29/2006 | US20060142227 Amphiphylic peptide-PNA conjugates for the delivery of PNA through the blood brain barrier |
| 06/29/2006 | US20060142226 siNA molecule comprising a double-stranded structure that down-regulates expression of cholesteryl ester transfer protein (CETP) , wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 06/29/2006 | US20060142225 siNA molecule comprising a double-stranded structure that down-regulates expression of cyclin dependent kinase-2 (CDK2) , wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 06/29/2006 | US20060142224 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/29/2006 | US20060142223 Methods for xenotopic expression of nucleus-encoded plant and protist peptides and uses thereof |
| 06/29/2006 | US20060142222 Novel gene relating to fibrotic conditions |
| 06/29/2006 | US20060142221 Vaccine |
| 06/29/2006 | US20060142220 Protein modification |
| 06/29/2006 | US20060142219 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 06/29/2006 | US20060142218 Method of controlling telomere length |
| 06/29/2006 | US20060142200 Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia |
| 06/29/2006 | US20060142193 Selective inhibition of rock1 in cardiac therapy |
| 06/29/2006 | US20060141602 Packaging of positive-strand RNA virus replicon particles |
| 06/29/2006 | US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals |
| 06/29/2006 | US20060141535 Hyaluronan receptor for endocytosis |
| 06/29/2006 | US20060141524 Novel kinases and uses thereof |
| 06/29/2006 | US20060141476 Growth arrest homeobox gene |
| 06/29/2006 | US20060141471 Assay for detection of renal cell carcinoma |
| 06/29/2006 | US20060141455 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 06/29/2006 | US20060141042 Hollow nanoparticle having modified cysteine residue and drug with the use thereof |
| 06/29/2006 | US20060141040 Injectable non-aqueous suspension |
| 06/29/2006 | US20060141020 Liposomes containing oligonucleotides |
| 06/29/2006 | US20060140990 Composition for topical treatment of mixed vaginal infections |
| 06/29/2006 | US20060140978 Constitutive transport enhancer (CTE); Rev Responsive element (RRE); coding sequence for HIV-1 Rev, and a coding sequence for a desired protein that comprises a coding sequence for an HIV structural protein that includes an RRE and at least one CTE; genetic vaccines, gene therapy |
| 06/29/2006 | US20060140975 Regulated bacterial lysis for gene vaccine vector delivery and antigen release |
| 06/29/2006 | US20060140969 Hypoallergenic polypeptides based on fish parvalbumin |
| 06/29/2006 | US20060140967 Immunotherapy; detecting CD8 expressing T cells; biodrugs generate an immune response to breast cancer and prostate cancer cells that express TARP (T cell receptor gamma Alternate Reading Frame Protein); vaccines |
| 06/29/2006 | US20060140965 Immunogenic compositions comprising a xenogenic prostate protein p501s |
| 06/29/2006 | US20060140950 Using interleukin-23 modulators to treat and prevent nervous system, gastrointestinal and autoimmune disorders |
| 06/29/2006 | US20060140947 Administering decitabine and tyrosine kinase inhibitor such as epidermal growth factor receptor family (EGFR); cancer therapy; chronic myelogenous leukemia |
| 06/29/2006 | US20060140943 Immunotherapy using modulators of notch signalling |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140922 Modified by introduction of nucleic acid molecule comprising a nucleic acid sequence encoding granulocyte macrophage-colony stimulating factor (GM-CSF) operably linked to a promoter; contains cancer antigen; immunotherapy |
| 06/29/2006 | US20060140921 Disimmortalizable mammalian chromaffin cell lines for cell therapy for pain |
| 06/29/2006 | US20060140920 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain |
| 06/29/2006 | US20060140910 Recombinant adenoviral vectors and methods of use |
| 06/29/2006 | US20060140909 Method of using adenoviral vectors with increased persistence in vivo |
| 06/29/2006 | US20060140908 Methods for inducing an immune response via oral administration of an adenovirus |
| 06/29/2006 | US20060140907 Central airway administration for systemic delivery of therapeutics |
| 06/29/2006 | US20060140875 Semi-soft C-class immunostimulatory oligonucleotides |
| 06/29/2006 | CA2595517A1 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 06/29/2006 | CA2592201A1 Neuromedin s and the use thereof |
| 06/29/2006 | CA2592153A1 Resistance genes |
| 06/29/2006 | CA2592099A1 Conserved hbv and hcv sequences useful for gene silencing |
| 06/29/2006 | CA2591611A1 Rnai inhibition of ctgf for treatment of ocular disorders |
| 06/28/2006 | EP1673468A2 Methods for identifying compounds for inhibiting fever |
| 06/28/2006 | EP1673391A1 MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES |
| 06/28/2006 | EP1597370B1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 06/28/2006 | EP1383897B1 Self-containing lactococcus strain |
| 06/28/2006 | EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 06/28/2006 | EP1218508B1 DNA sequences for the enhancement of feed efficiency and growth rate of pigs |
| 06/28/2006 | EP1214452B1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 06/28/2006 | EP1156789B9 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 06/28/2006 | EP1040185B9 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 06/28/2006 | EP0990041B1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 06/28/2006 | EP0897426B1 Matrix metalloprotease |
| 06/28/2006 | EP0832227B9 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 06/28/2006 | EP0797676B9 Recombinant adenoviral vector and methods of use |
| 06/28/2006 | EP0783585B1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 06/28/2006 | EP0727490B1 Human-origin prostacyclin synthase |
| 06/28/2006 | CN1793379A Blood vessel growth hormone gene recombined gland relative vrius carrier and its preparation process and application thereof |
| 06/28/2006 | CN1793372A Non-viruse gene transferring vector and its preparation and application thereof |
| 06/28/2006 | CN1793367A Tubercle bacillus recombined protein and expressing purefying method and application thereof |
| 06/28/2006 | CN1793361A Small interference RNA of sinalbin myroxin receptor mIL17RE gene its coding gene and application thereof |
| 06/28/2006 | CN1793360A siRNA sequence of inhibiting PCNA gene expressing and application thereof |
| 06/28/2006 | CN1793359A HBV specificity interference target point gene and its siRNA and application in anti HBV infecting thereof |
| 06/28/2006 | CN1793343A Tumourolytic anticancer recombined adenovirus with tumour target direction and idioctonia |
| 06/28/2006 | CN1261593C Use of IC 53 gene and its related product in diagnosing and treating colon cancer and reagent box for diagnosing colon canter |
| 06/28/2006 | CN1261592C Antigen polypeptide of IC53 gene product, use of auto-body in diagnosis and treating of arrhythmia cardimyopathy and reagent kit containing the polypeptide |
| 06/28/2006 | CN1261580C Plasmid of recombinant immunotoxin IP 10-DT 390 aimed at activating Th1 cell, and its preparing method and use |
| 06/28/2006 | CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof |
| 06/28/2006 | CN1261160C Hybrid yeast AIDS vaccine |
| 06/27/2006 | US7067649 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis. |
| 06/27/2006 | US7067635 For use in diagnostic methods, immunotherapy, gene therapy and as vaccines |
| 06/27/2006 | US7067630 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 06/27/2006 | US7067629 Sodium channel in dorsal root ganglia |
| 06/27/2006 | US7067496 Transplanting into dermis, least one hair follicle that has been modified ex vivo to contain nucleic acid molecule to introduce nucleic acid molecule into mammal |
| 06/27/2006 | US7067479 Compositions with enhanced antimicrobial efficacy against E. coli |
| 06/27/2006 | US7067318 Methods for transfecting T cells |
| 06/27/2006 | US7067317 Wound healing agent |
| 06/27/2006 | US7067310 Generation plasmid in prokaryotic cell; obtain cell, incubate with nucleotide sequences, transform cell, allow homologouus recombination to occur, recover recombinamt plasmid |
| 06/27/2006 | US7067309 Used for the transfer and expression of exogenous nucleotide sequences in a host cell or organism; gene therapy |
| 06/27/2006 | US7067281 Mammalian IAP gene family, primers, probes and detection methods |